Medical disclaimer: This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Only a licensed physician can diagnose hypogonadism and determine whether testosterone therapy is appropriate for you.
Low testosterone — clinically called hypogonadism — affects millions of men, yet most go undiagnosed for years. The symptoms overlap with common complaints like stress and aging, and a single lab number often tells an incomplete story. The result: men who could benefit from evaluation don’t pursue it, and men who shouldn’t pursue TRT sometimes do.
This guide explains what symptoms actually suggest low testosterone, which laboratory tests are required for a proper diagnosis, and what the evaluation process looks like when done correctly.
Key Takeaways
Low testosterone diagnosis requires two morning total testosterone draws below 300 ng/dL, not just one
Symptoms alone are not enough — lab confirmation is required by Endocrine Society and AUA guidelines
Free testosterone and SHBG are as important as total testosterone — a man with “normal” total T may be deficient in bioavailable testosterone
Common symptoms — fatigue, low libido, brain fog, mood changes — have many causes; labs distinguish hypogonadism from other conditions
LH and FSH identify whether the problem is in the testes (primary) or the brain/pituitary (secondary) — which changes the treatment approach
Hypogonadism can affect men of any age — it is not exclusively an older man’s condition
What Low Testosterone Actually Feels Like
The symptoms of hypogonadism are non-specific — meaning they can be caused by many different conditions. That is exactly what makes them easy to dismiss and easy to misattribute to stress, poor sleep, or “just getting older.” The clinical picture matters because no single symptom confirms low testosterone.
The Endocrine Society and AUA recognize the following as the most clinically associated symptoms of hypogonadism:
Symptoms associated with low testosterone — by clinical specificity
MOST SPECIFIC Decreased spontaneous erections, reduced testicular volume, loss of body/facial hair — strongly associated with hypogonadism when present
HIGH ASSOCIATION Low libido, erectile dysfunction, reduced ejaculate volume, depressed mood, difficulty concentrating
MODERATE Fatigue, low energy, decreased motivation, increased body fat, reduced muscle mass and strength, poor sleep quality
LESS SPECIFIC Mild anemia, reduced bone density (osteopenia), hot flashes in severe deficiency, cognitive changes — require labs to distinguish from other causes
Fig. 1 — Symptoms of hypogonadism by clinical specificity per Endocrine Society guidelines (2018). No symptom alone confirms low testosterone — lab confirmation is required.
Most men with low testosterone report a cluster of symptoms rather than one isolated complaint. Fatigue combined with reduced libido combined with difficulty building muscle — that combination raises clinical suspicion more than any single symptom. But it is the laboratory results that confirm or rule out the diagnosis.
What these symptoms are NOT caused by
Before attributing symptoms to low testosterone, a proper evaluation rules out other common causes: thyroid dysfunction, sleep apnea, iron deficiency anemia, depression, diabetes, and hyperprolactinemia can all produce fatigue, mood changes, and sexual dysfunction. This is one reason why self-diagnosing based on symptoms and pursuing testosterone without labs is clinically unsound — the actual cause may be missed entirely.
The Diagnostic Labs: What You Actually Need
A proper hypogonadism workup is not a single testosterone number. The Endocrine Society Clinical Practice Guideline and the AUA Testosterone Deficiency guideline both specify what a complete evaluation should include. This is what the labs are, what they show, and why each one matters.
Lab Test
Reference Range
Why It Matters
Total Testosterone (×2)
<300 ng/dL on 2 draws
Primary marker. Must be measured twice on separate mornings — levels fluctuate 15–20% day to day. A single draw is insufficient for diagnosis.
Free Testosterone
Lab-dependent; typically <5 ng/dL low
The biologically active fraction. A man with total T of 420 ng/dL and high SHBG may have very low free T — and be functionally hypogonadal despite a “normal” total.
SHBG
10–57 nmol/L
Sex hormone-binding globulin binds testosterone and makes it unavailable to tissues. High SHBG artificially inflates total T. Obesity lowers SHBG. Both scenarios distort total T interpretation.
LH (Luteinizing Hormone)
1.5–9.3 IU/L
Identifies whether hypogonadism is primary (testes not responding — LH will be high) or secondary (pituitary not signaling — LH will be low or normal). This determines the treatment approach.
FSH (Follicle-Stimulating Hormone)
1.5–12.4 IU/L
Critical for men considering fertility. Low FSH on TRT suppresses sperm production. Baseline FSH also helps assess testicular reserve before starting therapy.
Estradiol (E2)
10–40 pg/mL
Baseline estradiol establishes context. Elevated E2 relative to T (aromatization, especially in obesity) can cause symptoms that mimic low T. Tracked during TRT to avoid excess conversion.
Prolactin
<15 ng/mL
Elevated prolactin (hyperprolactinemia) suppresses LH/FSH and causes secondary hypogonadism. It may indicate a pituitary adenoma — a treatable cause that requires its own workup, not TRT.
CBC (Hematocrit)
38–50%
Baseline hematocrit before TRT. TRT raises red blood cell production — monitoring is required to prevent erythrocytosis (>54%), which increases clotting risk.
PSA
Age-dependent
Baseline PSA before starting TRT in men ≥40. Required for prostate safety monitoring. A PSA above age-appropriate range warrants urologic evaluation before TRT is initiated.
Table 1 — Complete pre-TRT laboratory panel per Endocrine Society (2018) and AUA (2018) guidelines. All labs should be drawn in the morning (before 10 AM) in a fasting or semi-fasting state. For a deeper breakdown of each marker, see the complete pre-TRT lab guide.
The morning draw rule — and why it matters
Testosterone follows a circadian rhythm: levels peak between 6–10 AM and decline through the afternoon. An afternoon testosterone draw can be 20–30% lower than the same man’s morning level. Guidelines require morning draws specifically to capture the daily peak. A low afternoon testosterone level is diagnostically unreliable and does not meet criteria for hypogonadism diagnosis. This is one of the most common errors in low-quality TRT evaluations.
Primary vs Secondary Hypogonadism: Why It Changes Everything
Once low testosterone is confirmed, the next step is understanding why. This changes the clinical approach significantly — and it is why LH and FSH are non-optional parts of the workup.
Primary vs Secondary hypogonadism — key differences
Primary Hypogonadism
Where: The testes themselves cannot produce adequate testosterone
LH/FSH: Elevated (brain is signaling but testes don’t respond)
Treatment: Addressing the underlying cause first may restore T; TRT or clomiphene are options
Fertility: May be preserved or restored — hCG or clomiphene can stimulate natural production
Fig. 2 — Primary vs secondary hypogonadism: different causes, different LH/FSH patterns, different treatment considerations. This distinction cannot be made from testosterone alone.
A younger man with secondary hypogonadism caused by obesity and sleep apnea may restore his testosterone through weight loss and CPAP treatment — without ever needing TRT. Starting TRT without identifying this would treat the symptom while missing the cause. This is why a thorough evaluation matters as much as the treatment itself.
For men who are considering having children, the type of hypogonadism affects fertility options significantly. The TRT and fertility guide covers these options in full before any treatment decision is made.
The “Normal Range” Problem
One of the most common frustrations men report: being told their testosterone is “normal” when they feel clearly symptomatic. This happens because standard laboratory reference ranges are broad — typically 300–1,000 ng/dL or wider — and “normal” in a statistical sense is not the same as “optimal” for a specific individual.
A man at 310 ng/dL is technically within the reference range at most labs — yet clinical guidelines consider him a candidate for evaluation given consistent symptoms
Reference ranges are derived from population data that includes men with obesity, chronic illness, and other conditions that suppress testosterone — they describe a heterogeneous population, not an optimal target
The Endocrine Society uses 300 ng/dL as a threshold for clinical evaluation — not because 301 ng/dL is healthy and 299 ng/dL is not, but as a guideline boundary that should be interpreted alongside clinical symptoms
Free testosterone may be low even when total testosterone is borderline — high SHBG in older men or men on certain medications can make “normal” total T clinically insufficient
The practical takeaway: a single number does not determine whether you need evaluation. Consistent symptoms in the presence of borderline laboratory values is a clinical picture that deserves a physician’s assessment — not dismissal based on a reference range.
Red Flags That Warrant Faster Evaluation
Most low testosterone presents gradually over months or years. Some presentations warrant more urgent evaluation because they suggest a potentially serious underlying cause:
Sudden onset of hypogonadism symptoms — rapid symptom development suggests acute cause (trauma, infection, vascular event) rather than gradual age-related decline
Very low testosterone (<150 ng/dL) — severe deficiency may indicate primary hypogonadism, pituitary tumor, or other structural cause requiring imaging
Elevated prolactin with low LH/FSH — hyperprolactinemia from a pituitary adenoma requires MRI, not TRT initiation
Headaches, visual field changes, or galactorrhea alongside low T — may indicate a pituitary mass; requires neuroimaging before any hormonal treatment
Bilateral testicular atrophy without prior cause — requires full reproductive endocrinology evaluation
A physician reviewing these findings will typically order a pituitary MRI and additional hormonal workup before any treatment is started. TRT in the presence of an undiagnosed pituitary tumor could mask the underlying condition and delay necessary treatment.
What a Proper TRT Evaluation Looks Like
Knowing what a thorough evaluation includes helps you identify whether what you are receiving meets clinical standards. The first TRT consultation guide covers this in full detail, but the key components are:
What a complete TRT evaluation should include
✓ Structured symptom assessment — validated questionnaire (AMS scale, ADAM questionnaire) or systematic symptom review across all domains: sexual, physical, cognitive, mood
✓ Two morning total testosterone draws — on separate days before 10 AM; a single draw is insufficient for diagnosis
✓ Free testosterone and SHBG — essential when total T is borderline; calculated free T using total T + SHBG + albumin
✓ LH, FSH, prolactin — determines primary vs secondary; rules out hyperprolactinemia as a reversible cause
✓ CBC, PSA, metabolic panel, estradiol — baseline for monitoring, prostate safety, and to rule out other causes of symptoms
✓ Thyroid function (TSH) — hypothyroidism produces many of the same symptoms as low T; must be ruled out
✓ Medical history and medication review — opioids, steroids, antifungals, and other medications can suppress testosterone; sleep apnea, obesity, and chronic illness are addressed
✓ Fertility discussion (if applicable) — sperm banking, hCG co-administration, or clomiphene alternatives discussed before the first dose if future fertility is a consideration
Fig. 3 — Components of a guideline-adherent TRT evaluation. A provider who prescribes TRT based on symptoms alone or a single testosterone draw is not following current clinical standards.
A provider who offers TRT based on a single testosterone draw, without LH/FSH, prolactin, or PSA, and without structured symptom assessment, is not following the standard of care outlined in current guidelines. The completeness of the evaluation protects you — both from missing a treatable underlying cause and from starting a therapy whose risk-benefit balance hasn’t been properly assessed.
Once TRT begins, ongoing monitoring is required. Hematocrit, PSA, testosterone levels, and symptom response are assessed at 3–6 months initially and then annually once stable. For a detailed breakdown of what TRT monitoring includes and why, the TRT side effects and monitoring guide covers each parameter and its clinical significance.
When TRT Is NOT the Answer
A proper evaluation sometimes reveals that TRT is not the appropriate next step — even with confirmed low testosterone. This includes:
Active desire for biological children — TRT suppresses sperm production. Men who want fertility in the near future should discuss clomiphene or hCG-based protocols before initiating TRT
Reversible secondary hypogonadism — if obesity, untreated sleep apnea, or a medication is driving the suppression, addressing that first is appropriate
Elevated PSA or known prostate concerns — urologic evaluation should precede any TRT initiation
Active or recent cardiovascular events — men within 6 months of MI or stroke should defer TRT initiation pending cardiac stabilization
Elevated hematocrit at baseline — men already above 50% hematocrit are at increased thrombotic risk from further erythrocytosis
Normal testosterone with non-hormonal symptoms — fatigue and low mood in a man with T of 620 ng/dL are not caused by testosterone deficiency; treatment would be ineffective and inappropriate
The goal of evaluation is to find out whether TRT is right for your specific clinical situation — not to confirm a decision already made. If you’ve been reviewing information about TRT and recognizing symptoms, the complete TRT guide provides the full clinical context from diagnosis through long-term management.
Frequently Asked Questions
What total testosterone level requires treatment?
The Endocrine Society guideline uses 300 ng/dL as the threshold below which TRT may be appropriate — but only when consistent symptoms are also present. Diagnosis requires two separate morning draws both below this threshold, plus clinical symptoms. There is no level that “automatically” requires treatment; the clinical picture and individual risk-benefit assessment determine the decision.
Can I have symptoms of low testosterone with a normal total T?
Yes — for two reasons. First, free testosterone (the biologically active fraction) can be low even when total testosterone is within the reference range, particularly in men with high SHBG. Second, individual variation means some men are symptomatic at levels others tolerate well. A complete evaluation including free testosterone and SHBG is needed before concluding that testosterone is not the cause of symptoms.
What time of day should testosterone be tested?
Between 7–10 AM. Testosterone follows a circadian rhythm and peaks in the early morning. An afternoon draw can read 20–30% lower than the same man’s morning level. Labs drawn after midday can produce results that appear low and do not accurately reflect testosterone status. Any evaluation using afternoon or random draws is diagnostically unreliable.
Do I need to fast before a testosterone blood test?
Fasting is not strictly required for testosterone measurement, but it is often recommended because eating — particularly a high-fat meal — can transiently suppress testosterone levels. Drawing blood in a fasting or semi-fasting state (no food 2–4 hours before) minimizes this variable and produces more consistent results. For labs that include metabolic panel or lipids, fasting is required regardless.
What if my doctor says my testosterone is normal but I have symptoms?
Ask specifically about free testosterone, SHBG, and where your total testosterone falls within the reference range. A total T of 320 ng/dL is technically “normal” by most lab standards but is at the lower boundary of clinical concern. If your provider dismissed symptoms without reviewing the complete panel, seeking a second opinion from a physician who specializes in men’s hormonal health is a reasonable next step.
How long does a proper TRT evaluation take?
A guideline-adherent evaluation requires two separate morning blood draws on different days — so the diagnostic phase alone spans at least one week, often two to four. Additional time may be needed if follow-up labs are indicated (e.g., pituitary MRI for elevated prolactin, urologic consultation for elevated PSA). Providers who offer TRT at the first appointment without repeat testing are skipping a required diagnostic step.
Can lifestyle changes raise testosterone without TRT?
For men with borderline testosterone and secondary hypogonadism driven by lifestyle factors, meaningful improvements are possible. Weight loss of 10–15% body weight in obese men can raise testosterone 100–200 ng/dL. Sleep optimization, resistance training, and alcohol reduction all support testosterone levels. These interventions are appropriate first-line approaches for secondary hypogonadism. For men with confirmed primary hypogonadism or testosterone consistently below 250 ng/dL, lifestyle changes alone are unlikely to produce clinically meaningful improvement.
Is there a difference between TRT evaluation at a regular doctor vs. a men’s health clinic?
The clinical standard should be the same — two morning testosterone draws, full hormone panel, symptom assessment, medical history. In practice, a physician with expertise in men’s hormonal health will typically order a more complete panel (free T, SHBG, LH, FSH, estradiol, prolactin) and interpret results in clinical context more reliably than a generalist who rarely manages hypogonadism. The credential to look for is a physician (MD/DO) with documented experience in endocrinology or men’s health — not a clinic that offers TRT at the first appointment without labs.
References
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115
Dohle GR, Arver S, Bettocchi C, et al. Guidelines on Male Hypogonadism. European Association of Urology. 2022. uroweb.org
Kelsey TW, Li LQ, Mitchell RT, et al. A validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40 years. PLoS One. 2014;9(10):e109346. doi:10.1371/journal.pone.0109346
Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metab. 2017;102(3):1067–1075. doi:10.1210/jc.2016-3580
Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161–1173. doi:10.1210/jc.2016-2935
Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107–117. doi:10.1056/NEJMoa2215025